Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2010

Verenium Corp. (VRNM) Updates on 2010 Accomplishments; 2011 Goals

Verenium, a company engaged in the development and commercialization of high-performance industrial enzyme solutions for biofuels, animal health and nutrition and more, yesterday announced its key 2010 accomplishments, as well as its goals and financial guidance for 2011. One of … Continue reading

Posted in Small Cap News | Leave a comment

Uranium Energy Corp. (UEC) Receives Mine Permit and Production Area Authorization for the Goliad ISR Project in South Texas

Uranium Energy Corp. announced today that the Commissioners of the Texas Commission on Environmental Quality (TCEQ) have approved the Mine Permit and the Production Area Authorization for Production Area One (PA-1). They have also granted the request for designation of … Continue reading

Posted in Small Cap News | Leave a comment

ADDvantage Technologies Group, Inc. (AEY) Posts Solid Q4, Full-year 2010 Results on Rising Demand

ADDvantage Technologies Group Inc., cable television supplier, today posted its financial results for the three and 12-month periods ended September 30, 2010, reflecting strength in spite of economic difficulties. “We are pleased with the increased revenues in fiscal year 2010 … Continue reading

Posted in Small Cap News | Leave a comment

Stone Energy Corp. (SGY) Announces 2011 Oil and Gas Capital Budget

Stone Energy Corp. issued the company’s official capital budget for oil and gas operations in 2011. The budget was recently approved by the Board of Directors of Stone Energy. Stone Energy Corp. has allocated $425 million in capital for 2011 … Continue reading

Posted in Small Cap News | Leave a comment

Zogenix, Inc.’s (ZGNX) Migraine Treatment Receives Top Ranking as Most Innovative Life Sciences Product

Zogenix, Inc., a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced that CONNECT, a regional San Diego nonprofit organization, has selected Zogenix’s migrane treatment SUMAVEL(R) DosePro™ Needle-free Delivery System as … Continue reading

Posted in Small Cap News | Leave a comment

Polonia Bancorp (PBNY) Strengthens Philadelphia Presence through Acquisition

Polonia Bancorp, holding company of Pennsylvania-based Polonia Bank (Nasdaq: PBNY), today announced Polonia Bank has acquired certain assets and a majority of the deposits of former Earthstar Bank. The acquisition was executed through a purchase and assumption agreement with the … Continue reading

Posted in Small Cap News | Leave a comment

SMART Technologies Inc. (SMT) Appoints Dr. Keith Lantz to Executive Team

Located in Calgary, Alberta, Smart Technologies has quickly built a name for themselves as a leading provider of collaboration solutions that transform the educational and business worlds. Today, Smart Technologies took a major step towards prominence when they announced that … Continue reading

Posted in Small Cap News | Leave a comment

FDA Gives Green Light to Bionovo, Inc. (BNVI) for Clinical Development of Unique Menopause Treatment

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women’s health and cancer, including Menerba, the company’s oral drug candidate for menopausal hot flashes. The company today announced that the U.S. … Continue reading

Posted in Small Cap News | Leave a comment

Cogo Group (COGO) Sets Sights on China’s Evolving HDTV Market

Cogo Group Inc. provides embedded solutions and software for the technology and industrial sectors in China. The company yesterday noted solid demand for HDTV in China, with subscribers in the area passing the 2 million mark in the fourth quarter … Continue reading

Posted in Small Cap News | Leave a comment

Arena Pharmaceuticals, Inc. (ARNA) Begins Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension

Arena Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral drugs that target G protein-coupled receptors in four major therapeutic areas. These areas are cardiovascular, central nervous system, inflammatory and metabolic diseases. The company announced today … Continue reading

Posted in Small Cap News | Leave a comment